BioHealth News Archive
Montgomery County to establish Institute for Health Computing in North Bethesda – Washington Business Journal
Montgomery County Executive Marc Elrich signed Thursday a multiagency agreement to launch a new higher education institute in North Bethesda dedicated to artificial intelligence…
Read More
Johnson & Johnson Innovation Names Awardees in the Innovations for Vets QuickFire Challenge: Lung Cancer & Physical Trauma | Johnson & Johnson Innovation
November 9, 2022 — Johnson & Johnson Innovation, together with Johnson & Johnson Office of Military and Veterans Affairs, announced that AmacaThera, Hawkeye Bio,…
Read More
AlphaFold’s new rival? Meta AI predicts shape of 600 million proteins
When London-based artificial-intelligence (AI) company DeepMind unveiled predicted structures for some 220 million proteins earlier this year, the trove covered nearly every protein from…
Read More
Immunomic Therapeutics, Inc. Receives FDA Fast Track Designation for ITI-3000, a pDNA Vaccine, in Development for the Treatment of Merkel Cell Carcinoma
November 08, 2022 08:30 AM Eastern Standard Time ROCKVILLE, Md.–(BUSINESS WIRE)–Immunomic Therapeutics, Inc. (ITI), a privately-held clinical-stage biotechnology company pioneering the development of LAMP-mediated…
Read More
Catalio Capital Management’s new $85M fund is financing biomedical founders in ‘special situations’ – Technical.ly
Catalio Capital Management, an investment firm with offices in Baltimore and New York City, this week announced the close of a new fund that…
Read More
Linshom Medical awarded $2.4M SBIR Fasttrack award from NIH (NHLBI) – World News Report – EIN Presswire
BALTIMORE, MARYLAND, UNITED STATES, November 8, 2022 /EINPresswire.com/ -- Linshom Medical was awarded a $2.4 Million Fasttrack SBIR grant from the National Institutes of…
Read More
NIH names Dr. Joni L. Rutter director of the National Center for Advancing Translational Sciences | National Institutes of Health (NIH)
Lawrence A. Tabak, D.D.S., Ph.D., who is performing the duties of the National Institutes of Health director, has selected Joni L. Rutter, Ph.D., as…
Read More
Lupus, coronary artery disease share genetic risk factors; data may lead to early testing
Researchers have identified shared genetic risk factors for systemic lupus erythematosus and coronary artery disease, according to data published in Cell Reports Medicine. The…
Read More
Good News for Small Businesses Seeking Government Funding for Research and Development: SBIR/STTR Programs Extended Through 2025 | Wilson Sonsini
Under the SBIR and STTR Extension Act of 2022 (the Act), signed into law last month, the Small Business Innovation Research (SBIR) and Small…
Read More
Innovation Lab Awarded Grant for ‘Move-D’ Elbow Brace | The Hearing Review
An Orange County-based startup, Innovation Lab, announced that it was awarded $30,000 in grant funding to help bring its “Move-D” mechanical elbow brace to…
Read More
MedTech Color Presents: The National Institutes of Health- Exploring SBIR/STTR Funding Opportunities
Join this collaborative webinar between MedTech Color and the National Institutes of Health on November 8th 2022 at 2:30 PM ET. Attendees will learn…
Read More
Top university entrepreneurship centers, programs announced at annual Global Consortium of Entrepreneurship Centers Conference | Rice News | News and Media Relations | Rice University
HOUSTON – (Nov. 2, 2022) – The largest crowd in the history of the Global Consortium of Entrepreneurship Centers (GCEC) Conference gathered last week…
Read More
BHI International soft landing company MIMETAS Elected Most Innovative Company of the Netherlands
LEIDEN, The Netherlands, November 02, 2022 / B3C newswire / -- MIMETAS is the winner of the Dutch Innovation Award 2022. This award recognizes the…
Read More
J.P. Morgan Launches New Life Sciences Private Capital Team Targeting Investments in Innovative Healthcare Companies
Stephen Squinto, Ph.D., Gaurav Gupta, M.D. and Anya Schiess join J.P. Morgan as Managing Partners Industry luminaries to act as Strategic Advisors to support new team NEW…
Read More
Emergent BioSolutions Presents Data from Phase 2 Study Evaluating Safety and Immunogenicity of Chikungunya Vaccine Candidate in Prior Recipients of Other Alphavirus Vaccines
GAITHERSBURG, Md., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced results from a Phase 2 study evaluating the safety and immunogenicity…
Read More